Alpha 212® is the isotope Lead-212 or ²¹²Pb. It is produced by AdvanCell's ²¹²Pb generator and powers our therapeutic pipeline.
AdvanCell routinely manufactures Alpha 212® through a fleet of AdvanCell generators enabling full control of the supply chain for global manufacture of a pipeline of targeted alpha therapies.
Proprietary ²¹²Pb production technology provides access to an unmatched supply of alpha isotopes to accelerate clinical development of a portfolio of alpha radioligand therapies.
Pancreatic and Breast Cancer
Our proprietary manufacturing platform capable of delivering a scalable solution to fully automated, GMP compliant manufacture of alpha radioligand therapies.
The generator provides an unmatched, GMP compatible, manufacturing platform to support rapid clinical development of alpha radioligand therapies.
The generator can be installed in a GMP manufacturing environment and flexibly deliver clinical scale ²¹²Pb every day on an ongoing basis.
Multiple generators can be operated in series providing the ability to safely scale production as required.
The generator produces a consistently radioisotopically pure product giving high quality assurance.